https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:43081 Tue 13 Sep 2022 12:19:26 AEST ]]> Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:56177 Mon 12 Aug 2024 10:05:37 AEST ]]>